antiviral

Documents about antiviral

• Ocoxin oral solution demonstrates antiviral properties in cellular models#287864Gestión del Repositorio Documental de la Universidad de Salamanca
• Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions#262294HAL (France)
• Decoding the antiviral potential of eugenol, thymol and vanillin against human cytomegalovirus infection.#327635Repisalud
• Nutritional Support During Antiviral Therapy for Hepatitis C#878906ClinicalTrials.gov
• Stopping Antiviral Treatment in Chronic Hepatitis B#886919ClinicalTrials.gov
• Polyphenols as Antiviral Agents: Their Potential Against a Range of Virus Types#318948HAL (France)
• Hijacking and subversion of macrophage antiviral functions by viruses#478496Europe PMC
• Antiviral Therapy for Patients With Liver Cancer After Surgery#980013ClinicalTrials.gov
• Medicinal plants as source of antiviral substances against respiratory syncytial virus#202284GUPEA
• TANK potentiates antiviral innate immunity by recruiting deubiquitinase USP46 to activate IKKε#362522PLOS
• Nanoparticles May Improve How Antiviral Compounds are Delivered for Herpes Virus 1#429914DigitalCommons@USU
• Atualizações no tratamento antiviral da peritonite infecciosa felina : uma revisão de literatura#680276Repositório Institucional da Universidade Federal de Sergipe
• Atypical antiviral gene discovered in a mosquito#291846HAL (France)
• "Metal-based compounds in antiviral and Antiparasitic research: Mechanistic insights from HIV NCp7 and leishmaniasis case studies".#190383PubMed
• Structure-Function Correlations of Commercial Fucoidan Extracts: Antioxidant, Antiviral, Antifungal, Antibacterial and Prebiotic Activities#235102HAL (France)
• MODERN TREATMENT OF HERPES VIRUS INFECTION AND PROBLEMS OF RESISTANCE TO ANTIVIRAL DRUGS#271096Zenodo (CERN)
• Evaluation of doravirine-based regimen population target in a large Italian clinical center#274658IRIS
• Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection#826199ClinicalTrials.gov
• DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)#836732ClinicalTrials.gov
• Antiviral activity of an N-allyl acridone against dengue virus#954378Koc University Digital Collections
• Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C#849120ClinicalTrials.gov
• ENDOGENOUS ANTIVIRAL PROPERTIES OF RED BLOOD CELL-DERIVED EXTRACELLULAR VESICLES AND THEIR AUGMENTATION OF ANTIVIRAL OLIGONUCLEOTIDE THERAPY#254781ScholarBank@NUS
• Rasputin/G3BP mediates subversion of antiviral immunity by o’nyong-nyong virus in <i>Anopheles coluzzii</i>#368473PLOS
• Synthesis and characterization of new HIV-1 antiviral agents#651452Dipòsit Digital de la Universitat de Barcelona
• The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B#886648ClinicalTrials.gov
• New Antiviral Drugs for Treatment of COVID-19#158058ClinicalTrials.gov
• Antiviral amide derivatives from Uvaria siamensis#971117HAL (France)
• A Competent Antiviral, Antimicrobial, Nontoxic Nanostructured Lipid Carrier System for Safe Use as a Hand Sanitizer: In Vitro and In Vivo Studies#314782Europe PMC
• MNS induces antiviral protection and suppresses inflammation.#193586NCBI PubMed Central
• Membrane-Anchored and Sequence-Oriented Antiviral Activity of Fusion-Inhibitory Lipopeptides Derived from the SARS-CoV-2 Spike Glycoprotein S2 Subunit#330407IRIS
• HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function#810082ClinicalTrials.gov
• From CRISPR functional genomics to synthetic interventions: engineering antiviral strategies.#122905NCBI PubMed Central
• EBV Triggers a Distinct Antiviral Response in HMC3 Cells#158269bioRxiv / medRxiv
• The regulation of innate antiviral immunity by TRIM56.#295246NCBI PubMed Central
• Filtru antibacterian și antiviral#322351EU Publications
• Direct Acting Antiviral-Post Authorization Safety Study#865721ClinicalTrials.gov
• Chloroquine as Antiviral Treatment in Coronavirus Infection 2020#875829ClinicalTrials.gov
• Proof of concept: targeted protein degradation of the stress granules component G3BP1 as an antiviral strategy against norovirus infection.#272044Apollo
• Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)#901016ClinicalTrials.gov
• Distinct biochemical phenotypes of HIV exposed infants driven by antiviral medication#266297bioRxiv / medRxiv
• Repurposing antiviral drugs as a new avenue for Klebsiella pneumoniae decolonization#279373bioRxiv / medRxiv
• Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents#330316HAL (France)
• Castrating the Virus: A Conceptual Framework for Pseudoreceptor‑Based Host‑Directed Antiviral Strategies#722094PhilArchive
• The Study of Short-range Antiviral Treatment During Pregnancy to Block Mother-to-child Transmission of Hepatitis B Virus and Withdrawal Time#993553ClinicalTrials.gov
• Assessing Antiviral Treatments in Early Symptomatic RSV#162526ClinicalTrials.gov
• SFTSV NSs protein is a novel tick antiviral RNAi response suppressor#205316Enlighten Research Data
• Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study#912569ClinicalTrials.gov
• Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases#916313ClinicalTrials.gov
• Circadian Clock Programming of Anticipatory Antiviral Immunity Gates Enteric Virus Infection Susceptibility#271967bioRxiv / medRxiv
• RNase III nucleases from diverse kingdoms serve as antiviral effectors#304507HAL (France)